iOx Therapeutics Ltd.
London
About iOx Therapeutics Ltd.
iOx Therapeutics Ltd. operates as an immuno-oncology company. Founded in February 2015 by Professor Cerundolo, iOx Therapeutics is a spin-out from the University of Oxford started to commercialize discoveries made as part of a long-running collaboration between Oxford and the Ludwig Institute for Cancer Research. iOx intends to develop and commercialize multiple synthetic lipid compounds discovered by a research team led by Professor Cerundolo.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $950.0K
- Last round: Convertible Note (Mar 2018)
Industries & Categories
Biopharma, Biotechnology, Health Care, Oncology, Therapeutics
Canonical: https://fsome.com/organization/iox-therapeutics-ltd-168159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.